NCP Flanders
choose your programme
Horizon Europe

Horizon Europe is the main Research and Innovation Funding Programme of the European Commission.

Horizon 2020

Horizon 2020 is the previous Funding Programme. There are no longer calls, but projects can run until 2024.

Digital Europe

Digital Europe is a Funding Programme focused on bringing digital technology to businesses, citizens and administrations.

Other EU Funding

There are many other relevant EU funding programmes, managed by several agencies and directorates.

Event Calendar

Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020

Info Day WIDERA Work Programme 2023-2025: new ERA call topics

APR
Mon
22
10:00 - 12:30

This was 1 week ago

Location

virtual

Programmes

This virtual info day aims to inform interested applicants about one postponed and two new ERA call topics in the Widening participation and strengthening the European Research Area (WIDERA) Work Programme 2023-2025 (publication expected end of April 2024). The call will open on 15 May 2024 and close on 25 September 2024. 

Speakers from the European Commission will present the new call topics and are joined by speakers from stakeholder organisations to further explain the benefits of the proposed actions.

Interested applicants will have an opportunity to ask questions during the event using the code #WIDERA in Slido.

The livestream is available in the announcement on the research and innovation community platform.

Programme

10.00 - 10.30 Experimentation and exchange of good practices for value creation

Action that supports translating available scientific knowledge and research results to innovative solutions, including through more experimentation, peer learning and testing of new models as well as trying out good practices in different environments.  

Target groups: Academia/Research, industry/SMEs, public administration/policy-makers.

10.30 - 11.30 Science comes to town

Action that offers an opportunity for a group of cities to jointly design and implement a vibrant and engaging year-long programme of activities, connecting local R&I communities with citizens and stakeholders around the topic of science and its role in society.

Target groups: City authorities in collaboration with universities, research organisations, civil society organisations.

11.30 - 12:30 Talent ecosystems for attractive early research careers – pilot

Action that supports organisational change and coordination of measures in academic and non-academic organisations to create a talent ecosystem with a large pool of R&I positions that provide intersectoral career opportunities for R&I talents.

Target groups: Universities, research and technology organisations and infrastructures, SMEs/industry, government entities and international organisations, civil society organisations. 

myOVERVIEW
- sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon 2020 & Horizon Europe.

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.